4 min read
Getting your antigen to stand out in the crowd
By Michael Trang on 03/16/2021
Here at Antibody Solutions, we believe that starting with the best possible input will yield the best possible output. A critical input for any antibody discovery program is the immunogen; i.e., what will be administered to the host animal to raise an antibody response? While it may seem complex, intact cells bearing your target antigen may be the best input. We explore that subject in this blog post through a series of frequently asked questions from our clients.
Topics: Insights Transgenic Animals antigen syngeneic
5 min read
COVID-19 Targets, Tools and Therapeutics (Part 2)
By Dr. John Kenney on 12/15/2020
Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery, and participation in in-house and client-sponsored discovery programs. In this new blog series, we examine questions such as: What are the potential targets to treat COVID-19 and its sequelae, and what are the strategies and tools to discover drugs to treat the disease?
Topics: Insights Covid SARS-CoV-2 Molecuar Modeling Transgenic Animals COVID-19
4 min read
Expanding the Repertoire of Antibody Drug Discovery with Lambda Light-Chain Models
By Joshua Lowitz on 11/30/2020
Accessing the Untapped Potential of 33% of Human IgG
Topics: Transgenic Animals Lambda Mouse lambda light chain
2 min read
Expanded Partnership Offers Antibody Solutions Clients Access to the Transgenic H2L2 Harbour Mice™ Platform
By Dr. John Kenney on 05/16/2019
Agreement Provides for Easy Access to the Transgenic H2L2 Harbour Mice™ Platform with Antibody Solutions’ Discovery and Development Services
Topics: News Transgenic Animals transgenic H2L2 mice Harbour
2 min read
A New Way to Solve Problematic Rat IgG Purification
By Dr. John Kenney on 05/10/2019
When you think about the rat IgG production and purification process (especially IgG2a), what words often come to mind? If you’re like most researchers, it’s probably a combination of these: frustration, missed timelines, low purity, and poor recovery.
Topics: Insights Transgenic Animals Monoclonal therapeutic monoclonal antibodies OmniRat igG MAbExpress IgG purification
Filter by Keyword
- Insights (32)
- COVID-19 (14)
- Covid (14)
- SARS-CoV-2 (14)
- Events (12)
- Molecuar Modeling (9)
- News (9)
- Transgenic Animals (5)
- antibody discovery (4)
- Therapeutic Targets (3)
- 25th Anniversary (2)
- Omicron (2)
- therapeutic monoclonal antibodies (2)
- ADC (1)
- Antibody-Drug Conjugate (1)
- CAR-T (1)
- Cell therapy (1)
- Functional Assays (1)
- Harbour (1)
- Hybridoma (1)
- IgG purification (1)
- Lambda Mouse (1)
- MAbExpress (1)
- Monoclonal (1)
- OmniRat (1)
- antigen (1)
- cell fusion (1)
- igG (1)
- immunoassays (1)
- immunogens (1)
- lambda light chain (1)
- mRNA (1)
- peptides (1)
- syngeneic (1)
- target analysis (1)
- transgenic H2L2 mice (1)
- women in bio (1)